These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 1382546
1. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-). Seshi B, Kashyap A, Bennett JM. Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546 [Abstract] [Full Text] [Related]
2. Acute myeloid leukemia M2 and t(8;21)(q22;q22) with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-), and CD33(-). García Vela JA, Martin M, Delgado I, García Alonso L, Monteserin MC, Benito L, Somolinos N, Oña F. Ann Hematol; 1999 May; 78(5):237-40. PubMed ID: 10391105 [Abstract] [Full Text] [Related]
3. [Immunologic characteristics and prognosis of acute myeloid leukemia M1]. Zhao F, Chen Y. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783 [Abstract] [Full Text] [Related]
4. Detection of myeloperoxidase by flow cytometry in acute leukemia. Nakase K, Sartor M, Bradstock. Cytometry; 1998 Aug 15; 34(4):198-202. PubMed ID: 9725460 [Abstract] [Full Text] [Related]
5. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia. Urbano-Ispizua A, Matutes E, Villamor N, Sierra J, Pujades A, Reverter JC, Feliu E, Cervantes F, Vives-Corrons JL, Montserrat E. Br J Haematol; 1992 Jun 15; 81(2):178-83. PubMed ID: 1322689 [Abstract] [Full Text] [Related]
6. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens]. Jiang NG, Chen XM, Zhu HL, Zhong L, Zeng TT, Jia YQ. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec 15; 18(6):1405-9. PubMed ID: 21176339 [Abstract] [Full Text] [Related]
7. CD4 predicts nonlymphocytic lineage in acute leukemia. Insights from analysis of 125 cases using two-color flow cytometry. Larson RS, McCurley TL. Am J Clin Pathol; 1995 Aug 15; 104(2):204-11. PubMed ID: 7543728 [Abstract] [Full Text] [Related]
8. Acquisition of CD13 and CD33 expression at relapse on acute myeloid leukemia cells with an unusual phenotype: MPO+CD13-CD33-. Kawada H, Ichikawa Y, Kobayashi N, Fukuda R, Yonekura S, Nagao T. Intern Med; 1993 Sep 15; 32(9):733-6. PubMed ID: 7908235 [Abstract] [Full Text] [Related]
10. Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia. Storr J, Dolan G, Coustan-Smith E, Barnett D, Reilly JT. J Clin Pathol; 1990 Oct 15; 43(10):847-9. PubMed ID: 1977771 [Abstract] [Full Text] [Related]
11. Enhanced myeloid specificity of CD117 compared with CD13 and CD33. Nomdedéu JF, Mateu R, Altès A, Llorente A, Rio C, Estivill C, López O, Ubeda J, Rubiol E. Leuk Res; 1999 Apr 15; 23(4):341-7. PubMed ID: 10229319 [Abstract] [Full Text] [Related]
12. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis. Klobusicka M, Kusenda J, Babusikova O. Neoplasma; 2005 Apr 15; 52(3):211-8. PubMed ID: 15875082 [Abstract] [Full Text] [Related]
13. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms. Nakase K, Kita K, Shiku H, Tanaka I, Nasu K, Dohy H, Kyo T, Tsutani H, Kamada N. Am J Clin Pathol; 1996 Jun 15; 105(6):761-8. PubMed ID: 8659452 [Abstract] [Full Text] [Related]
14. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta. Yoneda N, Tatsumi E, Teshigawara K, Nagata S, Nagano T, Kishimoto Y, Kimura T, Yasunaga K, Yamaguchi N. Am J Hematol; 1994 Apr 15; 45(4):310-20. PubMed ID: 7513945 [Abstract] [Full Text] [Related]
15. [Immunocytochemistry in the diagnosis of acute myeloid leukemia (M0)]. Saito M, Kuriyama K, Nagai K, Nonaka H, Hata T, Tusima H, Tabata S, Arimura K, Souda H, Nakamura H. Rinsho Ketsueki; 1994 Nov 15; 35(11):1297-304. PubMed ID: 7823396 [Abstract] [Full Text] [Related]
16. Surface marker expression in acute myeloid leukaemia at first relapse. Thomas X, Campos L, Archimbaud E, Shi ZH, Treille-Ritouet D, Anglaret B, Fiere D. Br J Haematol; 1992 May 15; 81(1):40-4. PubMed ID: 1381608 [Abstract] [Full Text] [Related]
17. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia. Praxedes MK, De Oliveira LZ, Pereira Wda V, Quintana IZ, Tabak DG, De Oliveira MS. Leuk Lymphoma; 1994 Jan 15; 12(3-4):233-9. PubMed ID: 8167554 [Abstract] [Full Text] [Related]
18. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, Chen IM, Whittaker MH, Griffith BB, Licht JD. Blood; 1994 Jul 01; 84(1):244-55. PubMed ID: 7517211 [Abstract] [Full Text] [Related]
19. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA. Am J Clin Pathol; 1998 Feb 01; 109(2):211-20. PubMed ID: 9583894 [Abstract] [Full Text] [Related]
20. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia. Kraguljac N, Marisavljevic D, Jankovic G, Radosevic N, Pantic M, Donfrid M, Miletic N, Boskovic D, Colovic M. Am J Clin Pathol; 2000 Jul 01; 114(1):29-34. PubMed ID: 10884796 [Abstract] [Full Text] [Related] Page: [Next] [New Search]